miR-21 has been shown as an indicator of clinical diagnostic approaches due to its ability to target proliferation signaling, tumor suppressor genes, metastasis and MDR-associated oncogenic function in HER2+BC. This evidence concerns the gene ERBB2 and breast cancer.